Disease Susceptibility clinical trials
The registry lists 37 studies for Disease Susceptibility across more than 10 countries. 4 are recruiting or about to start. 8 of them are mainly about Disease Susceptibility (how this is decided). Per ClinicalTrials.gov, last updated 2025-05-23. Counting its 2 narrower conditions too, such as Genetic Predisposition to Disease: 319 studies, 127 open.
Get an email when these change. Save the Disease Susceptibility studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Top Institute Pharma (2) · Fundación Pública Andaluza Progreso y Salud (2) · Assistance Publique - Hôpitaux de Paris (2) · University of Colorado, Denver (2) · Hospices Civils de Lyon (2) · Brigham and Women's Hospital (2) · Bionorica SE (2) · National Institute on Aging (NIA) (1)
What is being tested here
Drugs under test in Disease Susceptibility studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Epidemiologic and Genetic Study on Familial Prostate Cancer · Centre de Recherche sur les Pathologies Prostatiques
Who these studies take
Of the 4 Disease Susceptibility studies recruiting now, 2 (50%) set no upper age limit and 2 (50%) stop at 75 or younger. 2 (50%) take children under 18. 1 (25%) are for women only and 0 (0%) for men only; 3 (75%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (50%) | 2 (50%) |
| 18 | 3 (75%) | 2 (50%) |
| 30 | 2 (50%) | 1 (25%) |
| 40 | 2 (50%) | 1 (25%) |
| 50 | 2 (50%) | 1 (25%) |
| 65 | 2 (50%) | 1 (25%) |
| 75 | 2 (50%) | 1 (25%) |
| 85 | 2 (50%) | 1 (25%) |
Across all 37 studies, recruiting or not: 46% stop at 75 or younger and 38% at 65; 32% take children; 11% are for women only and 3% for men only; 62% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 37 of 37. search them.
- Epidemiologic and Genetic Study on Familial Prostate CancerRecruitingNCT012211681 country
- Association Between Genetic Polymorphisms and Type 2 Asthma in ChildrenRecruitingNCT068407171 country
- Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association StudyRecruitingNCT043720951 country
- Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed CancerRecruitingNCT049037821 country
- Susceptibility of Cardiorespiratory Responses to Ozone During Cycling ExerciseCompletedNCT05473000Not applicable1 country
- Prevention of Obesity in Women Via Estradiol RegulationCompletedNCT00687739Phase 31 country
- Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing BacteremiaTerminatedNCT056133223 countries
- Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air ForceCompletedNCT03276637Not applicable1 country
- Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic DermatitisCompletedNCT05807113Not applicable1 country
- Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic DermatitisCompletedNCT05786976Not applicable1 country
- CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of EnergyCompletedNCT00427193Not applicable1 country
- Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.CompletedNCT044028271 country
- GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese PopulationStatus unknownNCT023650771 country
- Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection)Status unknownNCT046441461 country
- The Healthy Start Project: Primary Prevention of Overweight in Preschool Children Susceptible to Future OverweightCompletedNCT01583335Not applicable1 country
- An Integrative Genomic Approach to Solve tHe Puzzle of sevERe earLy-Onset COPDStatus unknownNCT042639611 country
- Secondary Prevention of OsteoporosisCompletedNCT00421343Phase 31 country
- Susceptibility to Breast CancerCompletedNCT000045651 country
- Females, Aging, Metabolism, and ExerciseCompletedNCT01712230Not applicable1 country
- Evaluation of the Adhesion to the GENEPY NetworkStatus unknownNCT039796121 country
- REVEAL III: Risk Evaluation and Education for Alzheimer's DiseaseCompletedNCT00462917Not applicable1 country
- Clopidogrel Pharmacogenomics ProjectCompletedNCT01097343Phase 21 country
- Cefixime / Azithromycin pK StudyCompletedNCT02708992Phase 11 country
- Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)Status unknownNCT028298531 country
- Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early ComplicationsStatus unknownNCT022125221 country
- Rapid Identification and Susceptibility Testing of Pathogens From Blood CulturesCompletedNCT01898208Not applicable1 country
- Microbiological Evaluation of the Ocular Flora Before Cataract SurgeryCompletedNCT021246031 country
- Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by EnterobacteriaceaeCompletedNCT020051591 country
- Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.TerminatedNCT01875263Phase 31 country
- Prospective Population Study on Candidemia in SpainCompletedNCT012362611 country
- Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus AureusCompletedNCT01211470Phase 23 countries
- The Genetic and the Functional Study of DNA Repair System and the Susceptibility to Rheumatoid ArthritisCompletedNCT01285336Not applicable1 country
- Risk Evaluation and Education for Alzheimer's DiseaseCompletedNCT00571025Not applicable1 country
- Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT008508631 country
- Memory Imaging of Normal AgingCompletedNCT003155751 country
- Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPDStatus unknownNCT008074691 country
- Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves' DiseaseCompletedNCT00505011